Guangzhou Innogen Pharmaceutical Group Co Ltd Class H 2591

HKEX · Hong Kong SAR China · Health Technology

HKD 3.73-0.12 (-3.12%)

Market closed· Oct 2, 2026, 8:08 AM UTC· HKD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H 2591

HKEX · Hong Kong SAR China · Health Technology

HKD 3.73-0.12 (-3.12%)

Market closed· Oct 2, 2026, 8:08 AM UTC· HKD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-82.12% · 6MFull-screen chart

Open HKD 3.81High HKD 3.85Low HKD 3.58Close HKD 3.73Volume 364.00K

Oct 2, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: HKD 3.85
Day range: HKD 3.58 – HKD 3.85
52-week range: HKD 3.44 – HKD 48.36
Volume: 364.00K
Market cap: HKD 1.76B
Next earnings date: 2027-03-22
Avg. volume (1Y): 3.35M

Performance

1 week

-3.49%

1 month

+5.82%

3 months

-54.73%

6 months

-82.37%

Year to date

-87.74%

1 year

-90.65%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Country: Hong Kong SAR China
Exchange: HKEX
Shares outstanding: 420.29M
Employees: 193
ISIN: CNE1000071Q7
Beta: 1.18

Technical view

Below averages

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceAug 04, 2026

Innogen Pharmaceuticals Receives PIC/S GMP Certificatation, Accelerating Global Expansion of Efsubaglutide Alfa

Innogen Pharmaceuticals (HK.2591), a biopharmaceutical company dedicated to innovative drug discovery and industrialization in metabolic diseases, today announced that its Efsubaglutide alfa manufacturing facility in Suzhou has officially passed a compliance inspection conducted by the Brazilian National Health Surveillance Agency (ANVISA) in accordance with the Pharmaceutical Inspection Co-operation Scheme (PIC/S) Good Manufacturing Practice (GMP) standards, and has received the GMP certificate

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.